Document is current
Any future updates will be listed below
-
Authors
Zhang, Weili
Gu, Yuxin
Xue, Xiajuan
Li, Xudan
Wang, Weifeng
Wang, Ruowei
He, Jiahua
Li, Weihao
Xing, Yue
Lin, Yuguang
Peng, Jianhong https://orcid.org/0000-0002-0769-8195
-
Funding
Funding for this research was provided by:
Basic and Applied Basic Research Foundation of Guangdong Province (2025A1515012742)
Science and Technology Planning Project of Shenzen Municipality (JCYJ20220531094015034)
Beijing Xisike Clinical Oncology Research Foundation (Y-Gilead2024-PT-0006)
- License Information
-
More Information
Article History
Received: 25 June 2025
Accepted: 4 August 2025
First Online: 21 August 2025
Declarations
:
: Weili Zhang, Yuxin Gu, Xudan Li, Xiajuan Xue, Weifeng Wang, Ruowei Wang, Jiahua He, Weihao Li, Yue Xing, Yuguang Lin, and Jianhong Peng: have no financial conflicts of interest to disclose.
: This study received approval from the Institutional Research Ethics Committee of Sun Yat-sen University Cancer Center (Approval Number: B2023-272-01). Informed consent was obtained from all patients whose clinical data were used.
: All authors affirm that generative artificial intelligence (AI) and AI-assisted technologies were used solely to enhance the readability and language during the writing process, under human supervision and control, to ensure that the conclusions are correct, reliable, and unbiased. All authors assume ultimate responsibility and accountability for the content of the work.
: Approved for publication by all participants.
